Skip to main content

Table 3 Multivariable logistic regression with longitudinal serum uric acid change (ΔUA) from baseline to seven years later as a predictor of the metabolic syndrome and its components after seven years. The odds ratio (OR) is per 59 μmol/L UA increase. The group includes the subjects without MetS at baseline

From: Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study

  Number Cases OR 95 % CI P value
Risk of elevated blood pressure 3507 2693 1.16 [1.02–1.31] 0.021
Risk of elevated triglycerides 3507 888 1.20 [1.10–1.31] <0.001
Risk of low HDL 3506 528 1.18 [1.07–1.31] 0.001
Risk of elevated fasting glucose 3506 320 0.97 [0.86–1.10] 0.636
Risk of central obesity 3484 978 1.49 [1.33–1.66] <0.001
Risk of MetS 3477 586 1.28 [1.16–1.42] <0.001
  1. Covariates: sex, age, systolic blood pressure, total cholesterol, current smoking, physical activity, HbA1c, eGFR, alcohol consumption, use of diuretics, waist circumference, baseline UA
  2. Elevated blood pressure = blood pressure ≥ 130/85 mm Hg or treated for hypertension, elevated triglycerides = triglycerides ≥ 2.28 mmol/L if time since last meal <4 h and ≥1.7 mmol/L if time since last meal ≥4 h or use of lipid lowering drugs, low HDL = HDL < 1.03 mmol/L in men or <1.30 mmol/L in women, elevated fasting glucose = glucose ≥ 7.8 mmol/L if time since last meal <4 h and ≥5.6 mmol/L if time since last meal ≥4 h or treated for elevated glucose, central obesity = waist circumference ≥ 102 cm in men or ≥88 cm in women, MetS = three or more MetS components
  3. Abbreviations: ΔUA uric acid change, UA uric acid, OR odds ratio, BMI body mass index, CI confidence interval, HDL high-density lipoprotein, HBA1c hemoglobin A1c, eGFR estimated glomerular filtration rate, MetS metabolic syndrome